Unilever Plan To Grow Consumer Health By Acquisition, Meet US Tightening Of Merger Scrutiny

FTC, DoJ Reviewing Merger Guides Relevant To Deals Across Consumer Product Sector

Unilever, which has had three offers for GSK rebuffed, likely notes that the Federal Trade Commission and Department of Justice signal they will tighten scrutiny of deals that merge companies providing consumer-facing products and services.

The potential for US trade regulators requiring divestment of one or more OTC drug, dietary supplement or other health care brands likely hasn’t influenced nor will diminish Unilever PLC’s interest in acquiring GlaxoSmithKline plc’s consumer health care product portfolio.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Unilever Plan To Grow Consumer Health By Acquisition, Meet US Tightening Of Merger Scrutiny

FTC, DoJ Reviewing Merger Guides Relevant To Deals Across Consumer Product Sector

Read the full article – start your free trial today!

More from Deals

More from Business